An article by Elisabeth Leere Øiestad et al at the University of Oslo and other related institutions, published in the December 2021 issue of Journal of Sustainable Chemistry and Pharmacy, reported on combining a one-step miniaturized sample preparation technique using microsamples collected on Mitra® devices based on VAMS® technology.
The paper is entitled "Green and sustainable drug analysis – Combining microsampling and microextraction of drugs of abuse.” It describes the development and validation of common drugs of abuse analytes using a technique called Parallel Artificial Liquid Membrane Extraction, or PALME.
By combining dried blood microsampling with PALME, the research group was able to conclude that it is possible to conduct low-cost, high sample throughput, semi-automated miniaturized sample preparation to achieve an Eco-Scale score of 78, which fulfills green chemistry principles.
With the aim of reducing further environmental harm, one area of focus is to reduce the volume of organic solvents used in all aspects of chemistry and chemical engineering. Many solutions and approaches to this challenge are currently being explored.
One attractive option is to swap toxic or volatile solvents with more environmentally friendly alternatives, wherever possible. In analytical chemistry, scaling down solvent usage has also been a driver to development of microextraction techniques.
Another driver of advances in microextraction is the technological advancement of analytical instrumentation, which is becoming progressively more sensitive.
For example, thousands of metabolomic biomarkers can now be identified from only a few microliters of biological fluid — something that might have been considered “science fiction” only a couple of decades ago.
Microextraction techniques are also becoming highly compatible with extraction of analytes from biological microsamples, such as blood or urine specimens.
These microsamples can be collected from remote microsampling devices, such as Mitra® or hemaPEN® devices.
One such technique is liquid-liquid extraction, which has been used with great success by a number of research groups, including Merck Pharmaceuticals and Wythenshawe Hospital in the United Kingdom (UK). The microsampling work done by these organizations was summarized in a previous blog on the Neoteryx website.
Liquid-liquid extraction employs an aqueous containing solvent to allow blood components to desorb from the microsampling device. However, without adding a clean-up step, injecting these extracts onto an LC-MS/MS instrument can lead to deleterious matrix effects, or even contamination.
Thus, conducting a post liquid-liquid clean-up into a water immiscible organic solvent (such as MTBE) can lead to high extraction efficiency for some analytes and vastly reduced matrix effects. This is a two-step process which can be time-consuming, and also uses organic solvents. Since the goal is to simplify the workflow while also reducing the use of solvents, one solution could be to employ PALME.
PALME (Parallel Artificial Liquid Membrane Extraction) is a way to simulate a “back-extraction” in a one-shot extraction apparatus. Back-extraction is a technique where analytes are extracted from one phase, such as a basic aqueous solvent, into an organic layer.
Following this, a second extraction is conducted utilizing a fresh aqueous layer, which is now acidic. The change in pH suppresses or promotes analyte charge, which in turn promotes association with either layer, dependent on the analyte charge state.
PALME (conducted in 96 well plates) creates a three-way extraction in one step. The assay consists of two wells separated by a filter disk which can accept an organic solvent (~75 µL), forming a supported liquid membrane. The bottom well (donor well) accepts the sample, and a buffer that is set to a pH in order to suppress the analyte of interest. The top well (acceptor) hosts the liquid membrane.
On top of this membrane is a buffer, which is set at a pH to promote analyte ionization. The apparatus is then simply sealed and vortexed using the liquid membrane as an interface and pH gradient. Neutral hydrophobic analytes first partition into the organic layer, then when in contact with the top layer, if they become charged, partition into this. The top layer can then be directly injected onto an LC-MS/MS or is diluted prior to analysis.
A benefit of PALME is the relative low cost (<£1 per well). Moreover, users can fine-tune all three layers and often create a 3 x 3 x 3 extraction method development matrix giving 27 options. Elisabeth Leere Øiestad et al reported that this technique had been previously used on dried blood spot (DBS).
In this study, they embarked on evaluating PALME for the extraction of 13 basic drugs of abuse molecules from Mitra devices, which are based on volumetric absorptive microsampling.
The following drugs were spiked into blood to create calibrators and quality control samples:
We are now living in a global society where the term ‘less is more’ is being adopted in many areas and for many reasons. In bioanalytical research studies, less sample volume collected from study participants using devices like hemaPEN and Mitra means more samples can be collected and, thus, more timepoints can be investigated.
Furthermore, more volunteers can be recruited into studies with more efficiency across a wider geographic area, since self-sampling at home is enabled by these remote microsampling devices and the ability to mail the collected samples directly to the lab from the nearest post box.
Indeed, volumetric microsampling using either Mitra devices or the hemaPEN brings many of the aforementioned efficiency benefits to modern bioanalytical workflows.
For example, as reported in a previous blog in this series, a research group showed that it was quicker to process dried microsamples compared to standard wet blood tubes.
To conclude, as we transition away from traditional bioanalytical workflows to microextraction workflows such as PALME, the ‘less is more’ approach is certainly going to continue to bring more benefits to researchers, including reducing harm to the environment through reduced solvent usage.
This study paper was summarized for our readers by James Rudge, PhD, Neoteryx Technical Director. This is curated content. To learn more about the important research outlined in this blog, visit the original paper published in the Journal of Sustainable Chemistry and Pharmacy.
Image Credits: iStock, Neoteryx
You can access this microsampling report and other studies in our Technical Resource Library.